Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

By: via Benzinga
Large-cap biotech stocks should see healthy second-quarter results driven by strong demand and new products, a Citi analyst said ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.